All articles by Saleem Khawaja

Saleem Khawaja

Synthesis-to-Clinic®: integrating isotopic labeling and human ADME to reduce time to clinic

How integrating isotopic labeling and human absorption, distribution, metabolism, and excretion (ADME) studies has helped reduce the time it takes to get drugs to market.

Five Trends in Contract Drug Manufacturing Organisations

The trend toward outsourcing pharmaceutical development and manufacturing has accelerated during the Covid pandemic as pharma companies – globally – seek to streamline their own facilities, focus on core competencies and avoid product delays inherent in decentralized international manufacturing.

Moving off the critical path: Streamlining strategies for drug substance synthesis and manufacturing

Each molecule has unique requirements and challenges, and a variety of solutions for drug substance synthesis and manufacturing are available, so it is important to have a keen understanding of the strategies that can help streamline these processes

Rapidly Accelerate Development Timelines: The Integration of Drug Substance & Drug Product Development

Free Webinar The Integration of Drug Substance and Drug Product This webinar highlights how a fully integrated drug development program…

Reducing drug development risks & timeline delays: An Integrated Bioanalytical & Pharmacokinetics (PK) Strategy

Free Report Bioanalytical services to accelerate drug development Delivering rapid bioanalytical data is critical to drug development. From drug discovery,…

Rapidly Accelerate Development Timelines: The Integration of Drug Substance & Drug Product Development

Free Report Bioanalytical services to accelerate drug development Delivering rapid bioanalytical data is critical to drug development. From drug discovery,…